Ruth Goodall

2.9k total citations
47 papers, 893 citations indexed

About

Ruth Goodall is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ruth Goodall has authored 47 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 27 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Ruth Goodall's work include HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (27 papers) and HIV/AIDS drug development and treatment (24 papers). Ruth Goodall is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (27 papers) and HIV/AIDS drug development and treatment (24 papers). Ruth Goodall collaborates with scholars based in United Kingdom, Uganda and Australia. Ruth Goodall's co-authors include Diana M. Gibb, Hermione Lyall, David Dunn, Vania Giacomet, Abdel G. Babiker, Cissy Kityo, G R Kinghorn, R D Maw, Samantha Barton and Ivor Byren and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Ruth Goodall

43 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth Goodall United Kingdom	16	597	370	242	118	80	47	893
Cándida Medina Guinea-Bissau	15	459 0.8×	240 0.6×	286 1.2×	97 0.8×	58 0.7×	42	699
Jonathan Ainsworth United Kingdom	18	792 1.3×	515 1.4×	492 2.0×	236 2.0×	49 0.6×	44	1.2k
Henry Sunpath United States	19	914 1.5×	630 1.7×	245 1.0×	114 1.0×	35 0.4×	47	1.0k
Wisit Prasithsirikul Thailand	23	730 1.2×	331 0.9×	295 1.2×	238 2.0×	33 0.4×	54	997
Carmen Rodríguez Spain	13	467 0.8×	223 0.6×	361 1.5×	78 0.7×	64 0.8×	19	675
Pablo F. Belaunzarán-Zamudio Mexico	17	468 0.8×	188 0.5×	383 1.6×	192 1.6×	76 0.9×	59	843
Laurence Brunet United States	14	502 0.8×	178 0.5×	297 1.2×	194 1.6×	103 1.3×	78	844
Natasha Press Canada	13	825 1.4×	377 1.0×	431 1.8×	227 1.9×	55 0.7×	25	1.1k
Brenda Crabtree‐Ramírez Mexico	18	627 1.1×	266 0.7×	438 1.8×	198 1.7×	105 1.3×	80	919
Eknath Naik United States	15	339 0.6×	132 0.4×	168 0.7×	127 1.1×	52 0.7×	40	626

Countries citing papers authored by Ruth Goodall

Since Specialization

Citations

This map shows the geographic impact of Ruth Goodall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Goodall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Goodall more than expected).

Fields of papers citing papers by Ruth Goodall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Goodall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Goodall. The network helps show where Ruth Goodall may publish in the future.

Co-authorship network of co-authors of Ruth Goodall

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Goodall. A scholar is included among the top collaborators of Ruth Goodall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Goodall. Ruth Goodall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gurumurthy, Meera, et al.. (2025). Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial. PLOS Global Public Health. 5(4). e0004259–e0004259.

Fabiane, Stella M., Chen‐Yuan Chiang, Sarah Meredith, et al.. (2024). Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis. Tropical Medicine and Infectious Disease. 9(9). 211–211.

Crichton, Siobhan, Julie Jesson, E. Belfrage, et al.. (2023). Global variations in pubertal growth spurts in adolescents living with perinatal HIV. AIDS. 37(10). 1603–1615. 2 indexed citations

Asad, Hibo, Intira Jeannie Collins, Ruth Goodall, et al.. (2021). Mortality and AIDS‐defining events among young people following transition from paediatric to adult HIV care in the UK. HIV Medicine. 22(8). 631–640. 12 indexed citations

Mocumbi, Sibone, et al.. (2017). High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility study. PLoS ONE. 12(3). e0173243–e0173243. 14 indexed citations

Judd, Ali, Katja Doerholt, Carlo Giaquinto, et al.. (2016). Long - term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand. St George's Online Research Archive (St George's University of London). 1 indexed citations

Goodall, Ruth, Adele McCormick, Anne Kapaata, et al.. (2015). Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa. AIDS Research and Human Retroviruses. 31(10). 1032–1037. 11 indexed citations

Turkova, Anna, Ali Judd, Ruth Goodall, et al.. (2015). Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study. The Lancet HIV. 2(12). e530–e539. 18 indexed citations

Parry, Chris M., Adele McCormick, Anne Kapaata, et al.. (2015). Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLoS ONE. 10(9). e0137834–e0137834. 21 indexed citations

10.

Kityo, Cissy, Diana M. Gibb, Charles F. Gilks, et al.. (2014). High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial. PLoS ONE. 9(3). e90772–e90772. 9 indexed citations

11.

Feeney, Eoin R., Corine Chazallon, Niall O’Brien, et al.. (2011). Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial). HIV Medicine. 12(10). 602–609. 4 indexed citations

12.

Ndembi, N., Ruth Goodall, David Dunn, et al.. (2009). Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine‐Lamivudine plus Nevirapine and Zidovudine‐Lamivudine plus Abacavir. The Journal of Infectious Diseases. 201(1). 106–113. 43 indexed citations

13.

Read, Tim, Dianne Carey, Patrick Mallon, et al.. (2009). Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial. AIDS. 23(16). 2222–2223. 13 indexed citations

14.

Asboe, David, et al.. (2007). A virological benefit from an induction/maintenance strategy: the Forte trial.. PubMed. 12(1). 47–54. 9 indexed citations

15.

Goodall, Ruth, David Dunn, & Abdel G. Babiker. (2004). Interval‐censored survival time data: confidence intervals for the non‐parametric survivor function. Statistics in Medicine. 23(7). 1131–1145. 22 indexed citations

16.

Gibb, Diana M., et al.. (2003). Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. The Pediatric Infectious Disease Journal. 22(1). 56–62. 131 indexed citations

17.

Chan, Sarin, et al.. (2002). Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.. UCL Discovery (University College London). 6(1). 3–10. 37 indexed citations

18.

Dunn, David, Diana M. Gibb, Ruth Goodall, et al.. (2001). TIMING AND INTERPRETATION OF TESTS FOR DIAGNOSING PERINATALLY ACQUIRED HEPATITIS C VIRUS INFECTION. The Pediatric Infectious Disease Journal. 20(7). 715–716. 18 indexed citations

19.

Moore, David, et al.. (2000). How generalizable are the results of large randomized controlled trials of antiretroviral therapy?. HIV Medicine. 1(3). 149–154. 26 indexed citations

20.

Balfe, Peter, Michelle A. Penny, Philippa Easterbrook, et al.. (1998). Association between a Defective CCR-5 Gene and Progression to Disease in HIV Infection. AIDS Research and Human Retroviruses. 14(14). 1229–1234. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact